72.17
price down icon0.74%   -0.54
after-market After Hours: 72.17
loading
Mirum Pharmaceuticals Inc stock is traded at $72.17, with a volume of 428.53K. It is down -0.74% in the last 24 hours and down -2.88% over the past month. Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
See More
Previous Close:
$72.71
Open:
$71.92
24h Volume:
428.53K
Relative Volume:
0.60
Market Cap:
$3.63B
Revenue:
$379.25M
Net Income/Loss:
$-77.34M
P/E Ratio:
-44.76
EPS:
-1.6122
Net Cash Flow:
$-27.87M
1W Performance:
-0.50%
1M Performance:
-2.88%
6M Performance:
+82.34%
1Y Performance:
+79.93%
1-Day Range:
Value
$71.66
$73.58
1-Week Range:
Value
$71.43
$78.54
52-Week Range:
Value
$36.88
$78.54

Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile

Name
Name
Mirum Pharmaceuticals Inc
Name
Phone
650-667-4085
Name
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
Name
Employee
349
Name
Twitter
@mirumpharma
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
MIRM's Discussions on Twitter

Compare MIRM with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MIRM
Mirum Pharmaceuticals Inc
72.17 3.65B 379.25M -77.34M -27.87M -1.6122
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-24-25 Initiated TD Cowen Buy
Aug-11-25 Resumed Stifel Buy
May-19-25 Resumed H.C. Wainwright Buy
Apr-17-24 Initiated Stifel Buy
Dec-18-23 Reiterated H.C. Wainwright Buy
Nov-20-23 Resumed JP Morgan Overweight
Nov-13-23 Initiated Morgan Stanley Overweight
Oct-24-23 Initiated Cantor Fitzgerald Overweight
Oct-17-23 Resumed Evercore ISI Outperform
Sep-20-23 Initiated JMP Securities Mkt Outperform
Sep-01-22 Initiated Citigroup Buy
Sep-20-21 Initiated JP Morgan Overweight
Aug-07-20 Upgrade Raymond James Outperform → Strong Buy
Aug-03-20 Initiated H.C. Wainwright Buy
Jul-31-20 Initiated Piper Sandler Overweight
Jun-25-20 Initiated Robert W. Baird Outperform
Aug-12-19 Initiated Citigroup Buy
Aug-12-19 Initiated Evercore ISI Outperform
Aug-12-19 Initiated Guggenheim Buy
Aug-12-19 Initiated ROTH Capital Buy
Aug-12-19 Initiated Raymond James Outperform
View All

Mirum Pharmaceuticals Inc Stock (MIRM) Latest News

pulisher
12:06 PM

Why Mirum Pharmaceuticals Inc. stock remains undervalued2025 Market Trends & Long-Term Growth Stock Strategies - newser.com

12:06 PM
pulisher
10:48 AM

Technical signs of recovery in Mirum Pharmaceuticals Inc.Weekly Profit Summary & Stepwise Trade Execution Plans - newser.com

10:48 AM
pulisher
09:52 AM

How to build a custom watchlist for Mirum Pharmaceuticals Inc.Trade Volume Summary & Safe Capital Investment Plans - newser.com

09:52 AM
pulisher
08:26 AM

Is it time to cut losses on Mirum Pharmaceuticals Inc.Portfolio Risk Summary & AI Powered Market Trend Analysis - newser.com

08:26 AM
pulisher
08:10 AM

How to use a screener to detect Mirum Pharmaceuticals Inc. breakoutsProduct Launch & Real-Time Chart Pattern Alerts - newser.com

08:10 AM
pulisher
Oct 12, 2025

Volume spikes in Mirum Pharmaceuticals Inc. stock – what they mean2025 Trade Ideas & Verified Short-Term Plans - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

How to integrate Mirum Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 PreEarnings & Precise Buy Zone Identification - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Up 6.9%Should You Buy? - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The AI Journal

Oct 10, 2025
pulisher
Oct 10, 2025

Is Mirum Pharmaceuticals Inc. reversing from oversold territory2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Mirum Pharmaceuticals' (MIRM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

Can Mirum Pharmaceuticals Inc. (08D) stock survive global slowdownInflation Watch & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Is Mirum Pharmaceuticals Inc 08D a good long term investmentRisk Management Strategies & Affordable Portfolio Trading - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Will Mirum Pharmaceuticals Inc. rebound enough to break evenDollar Strength & Daily Profit Focused Screening - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Branded Website for Consumers 2025 - Medical Marketing and Media

Oct 09, 2025
pulisher
Oct 09, 2025

Mirum Pharmaceuticals stock hits all-time high at 78.23 USD - Investing.com

Oct 09, 2025
pulisher
Oct 09, 2025

Mirum Pharmaceuticals stock hits all-time high at 78.23 USD By Investing.com - Investing.com Australia

Oct 09, 2025
pulisher
Oct 09, 2025

What data driven models say about Mirum Pharmaceuticals Inc.’s futureJuly 2025 Opening Moves & Real-Time Market Sentiment Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will Mirum Pharmaceuticals Inc. stock recover faster than peersIndex Update & Risk Controlled Daily Trade Plans - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Custom watchlist performance reports with Mirum Pharmaceuticals Inc.2025 Trading Recap & Stock Portfolio Risk Control - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Mirum Pharmaceuticals Inc. stock near bottom after declineDollar Strength & Free Real-Time Market Sentiment Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Mirum Pharmaceuticals Inc. (08D) stock is listed among top recommendationsQuarterly Market Summary & Technical Pattern Recognition Alerts - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

How sentiment analysis helps forecast Mirum Pharmaceuticals Inc.Sell Signal & AI Enhanced Trading Signals - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Identifying reversal signals in Mirum Pharmaceuticals Inc.July 2025 Technicals & Daily Entry Point Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Mirum Pharmaceuticals, Inc. $MIRM Shares Sold by Wealth Enhancement Advisory Services LLC - MarketBeat

Oct 05, 2025
pulisher
Oct 03, 2025

Is Mirum Pharmaceuticals Inc. forming a bottoming baseQuarterly Performance Summary & Risk Controlled Stock Pick Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Price action breakdown for Mirum Pharmaceuticals Inc.Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com

Oct 03, 2025

Mirum Pharmaceuticals Inc Stock (MIRM) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Mirum Pharmaceuticals Inc Stock (MIRM) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Brege Laura
Director
Sep 11 '25
Sale
74.40
17,000
1,264,868
15,703
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Sep 12 '25
Sale
76.01
9,578
728,024
39,945
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):